Accomplishments Collaborative Projects And Future Initiatives In Breast Cancer Genetic Predisposition
Download Accomplishments Collaborative Projects And Future Initiatives In Breast Cancer Genetic Predisposition full books in PDF, epub, and Kindle. Read online free Accomplishments Collaborative Projects And Future Initiatives In Breast Cancer Genetic Predisposition ebook anywhere anytime directly on your device. Fast Download speed and no annoying ads. We cannot guarantee that every ebooks is available!
Author | : Paolo Peterlongo |
Publisher | : Frontiers Media SA |
Total Pages | : 141 |
Release | : 2019-10-16 |
Genre | : |
ISBN | : 288963132X |
In this eBook, we described the accomplishments, collaborative projects and future initiatives in the field of breast cancer genetic predisposition. More specifically, the articles included focused on aspects such as mutation screening in unexplored populations, identification and characterization of novel predisposing genes and mutations, and population screening.
Author | : |
Publisher | : |
Total Pages | : 1822 |
Release | : 2010 |
Genre | : |
ISBN | : |
Author | : United States. Congress. House. Committee on Appropriations. Subcommittee on the Departments of Labor, Health and Human Services, Education, and Related Agencies |
Publisher | : |
Total Pages | : 1830 |
Release | : 2010 |
Genre | : Political Science |
ISBN | : |
Author | : World Health Organization |
Publisher | : |
Total Pages | : 246 |
Release | : 2017-05-09 |
Genre | : Medical instruments and apparatus |
ISBN | : 9789241565462 |
This is the model list and clearing house of appropriate, basic, and priority medical devices based on the list of clinical interventions selected from clinical guidelines on prevention, screening, diagnosis, treatment, palliative care, monitoring, and end of life care. This publication addresses medical devices that can be used for the management of cancer and specifically describes medical devices for six types of cancer: breast, cervical, colorectal, leukemia, lung, and prostate. This book is intended for ministries of health, public health planners, health technology managers, disease management, researchers, policy makers, funding, and procurement agencies and support and advocacy groups for cancer patients.
Author | : United States. Congress. House. Committee on Appropriations. Subcommittee on the Departments of Labor, Health and Human Services, Education, and Related Agencies |
Publisher | : |
Total Pages | : 1734 |
Release | : 1998 |
Genre | : United States |
ISBN | : |
Author | : |
Publisher | : |
Total Pages | : 1032 |
Release | : 2005 |
Genre | : Cancer |
ISBN | : |
Author | : Bruce A. Chabner |
Publisher | : Lippincott Williams & Wilkins |
Total Pages | : 836 |
Release | : 2011-12-07 |
Genre | : Medical |
ISBN | : 1451148208 |
Updated to include the newest drugs and those currently in development, this Fifth Edition is a comprehensive reference on the preclinical and clinical pharmacology of anticancer agents. Organized by drug class, the book provides the latest information on all drugs and biological agents—their mechanisms of action, interactions with other agents, toxicities, side effects, and mechanisms of resistance. The authors explain the rationale for use of drugs in specific schedules and combinations and offer guidelines for dose adjustment in particular situations. This edition's introduction includes timely information on general strategies for drug usage, the science of drug discovery and development, economic and regulatory aspects of cancer drug development, and principles of pharmacokinetics. Eight new chapters have been added and more than twenty have been significantly revised. A companion website includes the fully searchable text and an image bank.
Author | : Israel Gomy |
Publisher | : BoD – Books on Demand |
Total Pages | : 106 |
Release | : 2019-12-18 |
Genre | : Medical |
ISBN | : 183968142X |
The field of medical genetics and genomics has been constantly revolutionized by new breakthroughs, which bring more knowledge into the etiology and help improve the health care of individuals with either rare or common diseases. Nevertheless, as technologies evolve, novel challenges emerge, both technically and ethically, so they must be prudentially addressed. Among the myriad applications of genomics in medicine, this book depicts a glimpse of the advances achieved that have been leading us to the personalized/precision medicine era.
Author | : |
Publisher | : |
Total Pages | : 524 |
Release | : 2004 |
Genre | : Environmental health |
ISBN | : |
Author | : Ari VanderWalde |
Publisher | : |
Total Pages | : 174 |
Release | : 2022 |
Genre | : |
ISBN | : 9783036528205 |
Nowhere is the explosion in comprehensive genomic testing more evident than in oncology. Multiple consensus guidelines now recommend molecular testing as the standard of care for most metastatic tumors. To aid in the advancement of this rapidly changing field, we intend this Special Issue of JPM to focus on technical developments in the genomic profiling of cancer, detail promising somatic alterations that either are, or have a high likelihood of being, relevant in the near future, and to address issues related to the pricing and value of these tests.The last few years have seen the cost of molecular testing decrease by orders of magnitude. In 2018, we saw the first “site-agnostic” drug approvals in cancer (for microsatellite unstable cancer (PD-1 inhibitors) and NTRK-fusions (TRK inhibitors)). Research on targetable mutations, determination of genetic “signatures” that can use multiple individual genes/pathways, development of targeted therapy, and insight into the value of new technology remains at the cutting edge of research in this field. We are soliciting papers that present new technologies to assess predictive biomarkers in cancer, original research (pre-clinical or clinical) that demonstrates promise for particular targeted therapies in cancer, and articles that explore the clinical and financial impacts of this paradigmatic shift in cancer diagnostics and treatment.